60
IRUS Total
Downloads
  Altmetric

A randomised comparison evaluating changes in bone mineral density in advanced prostate cancer: luteinising hormone-releasing hormone agonists versus transdermal oestradiol.

File Description SizeFormat 
1-s2.0-S0302283815012014-main.pdfPublished version1.91 MBAdobe PDFView/Open
Title: A randomised comparison evaluating changes in bone mineral density in advanced prostate cancer: luteinising hormone-releasing hormone agonists versus transdermal oestradiol.
Authors: Langley, RE
Kynaston, HG
Alhasso, AA
Duong, T
Paez, EM
Jovic, G
Scrase, CD
Robertson, A
Cafferty, F
Welland, A
Carpenter, R
Honeyfield, L
Abel, RL
Stone, M
Parmar, MK
Abel, PD
Item Type: Journal Article
Issue Date: 17-Dec-2015
Date of Acceptance: 26-Nov-2015
URI: http://hdl.handle.net/10044/1/30344
DOI: https://dx.doi.org/10.1016/j.eururo.2015.11.030
ISSN: 1421-993X
Publisher: Elsevier
Start Page: 1016
End Page: 1025
Journal / Book Title: European Urology
Volume: 69
Issue: 6
Copyright Statement: © 2015 European Association of Urology. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Sponsor/Funder: Cancer Research UK
Funder's Grant Number: C17093/A12443
Keywords: Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
Androgen-deprivation therapy
Bone mineral density
Prostate cancer
Transdermal oestradiol
ANDROGEN-DEPRIVATION THERAPY
PARENTERAL ESTROGEN
CONTROLLED-TRIAL
ZOLEDRONIC ACID
CALCIUM INTAKE
MEN
METAANALYSIS
METASTASES
CARCINOMA
FRACTURE
LHRH agonist
1103 Clinical Sciences
Publication Status: Published
Open Access location: http://www.ncbi.nlm.nih.gov/pubmed/26707868
Appears in Collections:Department of Surgery and Cancer